Cambridge, MA, United States of America

Matthew Parker

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Matthew Parker in Transgenic Plant Technology

Introduction

Matthew Parker is a notable inventor based in Cambridge, MA, who has made significant strides in the field of biotechnology through his research and innovation. With two patents to his name, Parker has focused on novel solutions that enhance animal health and performance using transgenic plants.

Latest Patents

Parker's latest patents revolve around the development of immunomodulating transgenic plants. These plants are engineered to express one or more antagonist IL-10R peptides along with anti-IL-10 single domain antibodies. The primary application of these biotechnological advancements is to stimulate or modulate the immune system of animals and improve their gastrointestinal physiology. These transgenic plants and their derived tissues serve as effective animal feed additives, not only enhancing animal performance but also providing methods to treat infections caused by gastrointestinal pathogens.

Career Highlights

Throughout his career, Matthew Parker has dedicated himself to advancing agricultural biotechnology. His work at Agrivida, Inc. has positioned him as a key player in his field, focusing on innovations that link plant genetics with animal health. The impact of his work is evident in the potential applications of his patents, which aim to revolutionize how animal nutrition is approached in the industry.

Collaborations

Parker has had the opportunity to collaborate with esteemed colleagues, including R. Michael Raab and Oleg Bougri. These collaborations not only demonstrate Parker's ability to work within a team but also highlight the collective effort required to drive forward innovative solutions in biotechnology.

Conclusion

In summary, Matthew Parker's contributions to the realm of immunomodulating transgenic plants underscore the important intersection of plant biotechnology and animal health. His patents represent a forward-thinking approach that addresses significant challenges in the agricultural sector, helping to pave the way for future advancements in animal feed and health management. The work he continues to do with Agrivida, Inc. ensures that he remains at the forefront of innovation in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…